Neonatal hyperbilirubinemia (NHB) is a common clinical disease and can cause bilirubin encephalopathy in severe cases,which may lead to serious sequelae such as hearing impairment, visual abnormality and mental retardation in children. Quantitatively evaluating the degree of brain damage in neonates with hyperbilirubinemia is of great significance for the prognosis of neonates.In this study, T1 value was measured in different brain regions of newborns with different serum bilirubin levels using T1 mapping, a new magnetic resonance imaging technology of 3.0T.The threshold value of T1 in neonates with bilirubin brain injury was obtained.It provides the quantitative reference index of neonatal hyperbilirubin brain damage for clinic.
Bilirubin encephalopathy often lacks specific symptoms and is easy to be missed during the warning period, which makes treatment often lag behind1,2.Hyperbilirubinemia in some "healthy children" is likely to be overtreated, so it is far from sensitive to the diagnosis of bilirubin encephalopathy based solely on clinical symptoms and serum bilirubin levels, and it is impossible to detect the neurotoxic effects of bilirubin in the early reversible stage of treatment3,4.T1 mapping technique was used to measure T1 value of different brain region with different bilirubin levels in neonates5-7. Therefore, the threshold value of hyperbilirubin brain injury is obtained, which provides a quantitative reference index for the early prevention and treatment of neonatal bilirubin brain damage8.
I would like to thank my beloved mentor professor Ren Zhuanqin for his guidance and instruction on my study and life.
I would like to thank professor Wei Xiaocheng of GE for his thoughtful guidance and instruction in the subject design and abstract writing.
Thank my family for giving me academic support, life care and spiritual power!
[1]Manchanda S,Prasad A,Baruah B P.MRI findings in kernicterus[J]. Indian J Pediatr,2013,80( 2) : 181-182.
[2]Wisnowski J L,Panigrahy A,Painter M J,et al. Magnetic resonance imaging of bilirubin encephalopathy: current limitations and future promise[J].Semin Perinatol,2014,38( 7) : 422-428.
[3] Sari S,Yavuz A,Batur A,et al. Brain magnetic resonance imaging and magnetic resonance spectroscopy findings of children with kernicterus[J].Pol J Radiol,2015,11( 80) : 72-80.
[4] Watchko J F,Painter M J,Panigrahy A.Quantitative ADC in bilirubin encephalopathy[J].Jpn J Radiol,2013,31 ( 4) :299-300.
[5] Vrenken H,Jeroen J,et al. Whole-Brain T1 Mapping in Multiple Sclerosis: Global Changes of Normal-appearing Gray and White Matter [J]. Radiology,2006,240(3):811-820.
[6] Niepel G,Paul T,et al. Deep gray matter and fatigue in MS: a T1 relaxation time study[J]. J Neurol ,2006,253(13):896-902.
[7] Salerno M,Kramer CM. Advances in parametric mapping with CMR imaging[J]. JACC Cardiovasc Imaging,2013,6(7):806-822.
[8] Ding Y,Rao SX,Zhu T,et al. Liver fibrosis staging using T1 mapping on gadoxetic acid-enhanced MRI compared with DW imaging[J]. Clin Radiol,2015,70(10):1098-1103.
[9] Ruifang Y,Dongming H,et al. Diagnostic value of conventional MRI combined with DTI for neonatal hyperbilirubinemia [J]. Pediatr Neonatol,2017,8(3):1-7.
[10] Wisnowski JL, Panigrahy A, Painter MJ, Watchko JF. Magnetic resonance imaging abnormalities in advanced acute bilirubin encephalopathy highlight dentato-thalamo-cortical pathways[J] . J Pediatr 2016,174(3):260-263.
[11] Shah B,Anderson SW,Scalera J,et al. Quantitative MR imaging: physical principles and sequence design in abdominal imaging[J]. Radiogragphics,2011,31(3):867-880.
[12] Kim SG,Hu X,Ugurbil K.Accurate T1 determination from inversion recovery imaging:Application to human brain at 4 Tesla.Magn reson Med,1994,31(4):445-449.
[13] Coolen BF, Poot DH, Liem MI, et al. Threedimensional quantitative T1 and T2 mapping of the carotid artery: sequence design and in vivo feasibility [J]. Magn Reson Med, 2016,75(3):1008-1017.